Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tenet Healthcare Corporation (THC) vs Vale SA (VALE) Price & Performance

Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

Tenet Healthcare Corporation vs Vale SA — how do they compare? Tenet Healthcare Corporation trades at $262.03 (market cap $20.98B), while Vale SA trades at $13.6 (market cap $57.32B). The key difference: Vale SA is far larger — about 2.7× Tenet Healthcare Corporation's market cap, and Vale SA pays a 8.87% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and Vale SA for 109 Days on average.

THCVALE
Market Cap
$20.98B$57.32B
Volume
428,00827,996,846
Sector
HealthBasic Materials
52-Week High
$280.77$17.82
52-Week Low
$161.37$10.75
Typical Hold Time
15 Days109 Days
Enterprise Value
$32.06B$73.56B
Dividend Yield
—8.87%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.

THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.

Vale SA

VALE trades at $13.61, down 3.34% amid broader market weakness in steel producers. The stock shows bearish technical signals with recent earnings misses in Q4 2025 and Q1-Q2 2026. Fundamentals reveal declining revenue from $43.8B in 2022 to $38.4B in 2025, with net income margin compressing to 5.11%. Analyst consensus remains mixed with 32% buy ratings but a $16.21 price target suggesting 19% upside potential.

VALE faces headwinds from iron ore price volatility and rising operational costs, though its base metals segment shows growth potential. The current valuation at P/E 26.84 appears stretched given earnings pressure. Key risks include Brazilian regulatory exposure and cyclical commodity dependence, while the dividend yield of approximately 2.9% provides some income support.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

THC

No sentiment data available yet.

VALE
96% Buy4% Sell
Avg holding period · 109 Days

Top news

Latest headlines on both assets

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →

About Vale SA

Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.

Read more on VALE →